Aytu Biopharma (AYTU) FCF Margin (2013 - 2026)
Aytu Biopharma (AYTU) reported FCF Margin of 33.7% for Q1 2026, up 166.0% year-over-year from 12.67% in Q1 2025, and down 239.69% quarter-over-quarter from 24.12% in Q4 2025.
Aytu Biopharma (AYTU) FCF Margin (2013 - 2026) Analysis & Trends
Aytu Biopharma (AYTU) has 14 years of FCF Margin data on file, last reported at 33.7% in Q1 2026.
- FCF Margin for Q1 2026 came in at 33.7%, up 166.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 2.9% (up 1212.0% YoY), and the FY2025 annual result was 3.26%, down 63.0% from the prior year.
- FCF Margin declined to 33.7% in Q1 2026 per AYTU's latest filing, from 24.12% in the prior quarter.
- Over five years, FCF Margin peaked at 30.47% in Q2 2023 and troughed at 37.67% in Q1 2022.
- A 5-year average of 7.1% and a median of 7.65% in 2024 frame the typical range for FCF Margin.
- The sharpest annual moves came in 2022 and 2023: FCF Margin tumbled 5457 bps in 2022, then surged 5632 bps in 2023.
- A 5-year view of FCF Margin shows it stood at 9.51% in 2022, then soared by 92 bps to 0.72% in 2023, then surged by 2582 bps to 17.87% in 2024, then soared by 35 bps to 24.12% in 2025, then slumped by 240 bps to 33.7% in 2026.
- Business Quant data shows AYTU's FCF Margin at 33.7% in Q1 2026, 24.12% in Q4 2025, and 4.45% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -5.22% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 12.86% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 46.39% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 16.78% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | -2.77% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -429.96% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 32.62% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 13.24% |
| 10 | Aytu Biopharma | 24.18 Mn | -2.54 Mn | 7.60 Mn | -33.70% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -33.70% |
| Dec 31, 2025 | 24.12% |
| Sep 30, 2025 | -4.45% |
| Jun 30, 2025 | 18.41% |
| Mar 31, 2025 | -35.36% |
| Dec 31, 2024 | 17.87% |
| Sep 30, 2024 | -8.00% |
| Jun 30, 2024 | -7.65% |
| Mar 31, 2024 | -1.81% |
| Dec 31, 2023 | -0.72% |
| Sep 30, 2023 | -1.18% |
| Jun 30, 2023 | 30.47% |
| Mar 31, 2023 | -12.73% |
| Dec 31, 2022 | -9.51% |
| Sep 30, 2022 | -32.91% |
| Jun 30, 2022 | -25.85% |
| Mar 31, 2022 | -37.67% |
| Dec 31, 2021 | -38.15% |
| Sep 30, 2021 | -17.31% |
| Jun 30, 2021 | 28.72% |